Why we invested in Opo Bio 

At WNT Ventures, we pride ourselves on identifying and nurturing groundbreaking companies that have the potential to revolutionise industries. Our recent investment in Opo Bio, a synthetic biology company focused on cultivated meat and ingredients is a testament to this commitment. Here’s why we chose to back Opo Bio and why we believe in its potential. 

A Groundbreaking Approach to Enable a Growing Market 

Opo Bio stands out in the synthetic biology industry due to its innovative approach to creating high-quality cell lines, which can be used in a range of applications, such as structured meat products or animal-free ingredients. This approach not only sets Opo Bio apart but, also, enables the growing demand for sustainable and ethical meat alternatives. With the latest funding, Opo Bio is poised to expand into other high-value animal ingredients, such as fats and collagen, opening up new markets and opportunities.  

Experienced and Visionary Leadership 

One of the critical factors in our decision to invest in Opo Bio is the strength of its leadership team. Led by a group of experienced professionals with deep expertise in biotechnology, food science, and commercial strategy, the team has a clear vision for the company’s growth and the execution capabilities to achieve it.  

Strategic Partnerships and Support 

Opo Bio has already secured key partnerships with industry leaders and research institutions, which will be instrumental in accelerating product development and market entry. These collaborations provide the company with access to cutting-edge research, technological advancements, and a network of industry contacts that will be crucial as it scales its operations. Additionally, Opo Bio’s alignment with global sustainability goals makes it an attractive partner for organisations looking to invest in the future of food. 

A Focus on Sustainability 

At WNT Ventures, we are committed to supporting companies that contribute to a more sustainable future. Opo Bio’s mission to produce key ingredients using fewer resources and with a significantly lower environmental impact aligns perfectly with our investment philosophy. The company’s technology has the potential to reduce greenhouse gas emissions, land use, and water consumption associated with traditional livestock farming, making it a compelling investment for those concerned about the planet's future. 

Enhancing Founder Equity 

At WNT Ventures, we recognize the importance of keeping founders motivated and aligned with the company’s long-term success. In this funding round, we worked closely with Opo Bio and its existing shareholders to create a path for increasing founder equity. This adjustment strengthens the founders' stake in the company, ensuring their incentives remain closely tied to the performance and growth of the business. We believe this move will help sustain the entrepreneurial spirit and drive which have been central to Opo Bio’s achievements. 

 

A comment from the founders 

Over the past two years, we’ve grown from our first employee to a team of eight, launched and sold cell products globally, and partnered with cultivated meat companies and research teams across the world. This was enabled by the support of our Seed investors, but it's only the beginning of our story. We are thrilled to welcome WNT to our investor base and drive Opo's growth into its next phase, where we will diversify our technology and expand our commercial offerings into new B2B ingredient categories, including cell-based collagen. 

WNT is a valuable addition to our existing group of investors, bringing extensive networks, hands-on experience in building deep-tech companies, and expertise in the B2B high-value ingredient sector. Working with WNT during due diligence was refreshing—they truly understand deep-tech companies, the importance and value of different forms of intellectual property, and the unique challenges that companies like Opo encounter. 

 

The Path Forward 

Our investment in Opo Bio reflects our belief in the transformative potential of synthetic biology and the company’s ability to lead in this space. We are excited to support Opo Bio on its journey to create a more sustainable and ethical food and ingredients system. As the company continues to innovate and grow, we look forward to seeing the positive impact it will have on the world. 

 

MJ Alvarez and Grace Holland.